<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2113</number>
    <updateDate>2023-01-11T13:44:08Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:44:08Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2019-04-08</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 60 (Monday, April 8, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. NEAL:H.R. 2113.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 1[Page H3129]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2019-04-09T19:02:15Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Discharged from</name>
            <date>2020-12-24T14:49:37Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2019-04-08T16:00:52Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2019-04-08T15:23:16Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2020-12-24T14:48:48Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2019-04-09T15:31:25Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2019-04-08T16:00:47Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 116-688</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Drug Price Transparency Act</title>
        <congress>116</congress>
        <number>2087</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-05-21</actionDate>
          <text>Subcommittee Hearings Held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act</title>
        <congress>116</congress>
        <number>2115</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-10-29</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Strengthening Average Sales Price Reporting Act of 2019</title>
        <congress>116</congress>
        <number>2051</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-06-28</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.</title>
        <congress>116</congress>
        <number>2064</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-05-21</actionDate>
          <text>Subcommittee Hearings Held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>SPIKE Act</title>
        <congress>116</congress>
        <number>2069</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-05-21</actionDate>
          <text>Subcommittee Hearings Held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-12-24</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 571.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00571</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2020-12-24</actionDate>
        <text>Committee on Energy and Commerce discharged.</text>
        <type>Discharge</type>
        <actionCode>H12300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-12-24</actionDate>
        <text>Committee on Energy and Commerce discharged.</text>
        <type>Committee</type>
        <actionCode>5500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-12-24</actionDate>
        <text>Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-688, Part I.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-12-24</actionDate>
        <text>Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-688, Part I.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-04-09</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-09</actionDate>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-09</actionDate>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-08</actionDate>
        <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-04-08</actionDate>
        <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-04-08</actionDate>
        <committees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-08</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2019-04-08</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>N000015</bioguideId>
        <fullName>Rep. Neal, Richard E. [D-MA-1]</fullName>
        <firstName>RICHARD</firstName>
        <lastName>NEAL</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>E.</middleName>
        <district>1</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B000755</bioguideId>
        <fullName>Rep. Brady, Kevin [R-TX-8]</fullName>
        <firstName>KEVIN</firstName>
        <lastName>BRADY</lastName>
        <party>R</party>
        <state>TX</state>
        <district>8</district>
        <sponsorshipDate>2019-04-08</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000133</bioguideId>
        <fullName>Rep. Van Drew, Jefferson [D-NJ-2]</fullName>
        <firstName>Jefferson</firstName>
        <lastName>Van Drew</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>2</district>
        <sponsorshipDate>2019-04-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000467</bioguideId>
        <fullName>Rep. Finkenauer, Abby [D-IA-1]</fullName>
        <firstName>Abby</firstName>
        <lastName>Finkenauer</lastName>
        <party>D</party>
        <state>IA</state>
        <district>1</district>
        <sponsorshipDate>2019-04-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001085</bioguideId>
        <fullName>Rep. Houlahan, Chrissy [D-PA-6]</fullName>
        <firstName>Chrissy</firstName>
        <lastName>Houlahan</lastName>
        <party>D</party>
        <state>PA</state>
        <district>6</district>
        <sponsorshipDate>2019-04-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000606</bioguideId>
        <fullName>Rep. Raskin, Jamie [D-MD-8]</fullName>
        <firstName>Jamie</firstName>
        <lastName>Raskin</lastName>
        <party>D</party>
        <state>MD</state>
        <district>8</district>
        <sponsorshipDate>2019-04-29</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001209</bioguideId>
        <fullName>Rep. McAdams, Ben [D-UT-4]</fullName>
        <firstName>Ben</firstName>
        <lastName>McAdams</lastName>
        <party>D</party>
        <state>UT</state>
        <district>4</district>
        <sponsorshipDate>2019-05-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>U000040</bioguideId>
        <fullName>Rep. Underwood, Lauren [D-IL-14]</fullName>
        <firstName>Lauren</firstName>
        <lastName>Underwood</lastName>
        <party>D</party>
        <state>IL</state>
        <district>14</district>
        <sponsorshipDate>2019-05-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001208</bioguideId>
        <fullName>Rep. Slotkin, Elissa [D-MI-8]</fullName>
        <firstName>Elissa</firstName>
        <lastName>Slotkin</lastName>
        <party>D</party>
        <state>MI</state>
        <district>8</district>
        <sponsorshipDate>2019-05-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000563</bioguideId>
        <fullName>Rep. Lipinski, Daniel [D-IL-3]</fullName>
        <firstName>Daniel</firstName>
        <lastName>Lipinski</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>William</middleName>
        <district>3</district>
        <sponsorshipDate>2019-05-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000397</bioguideId>
        <fullName>Rep. Lofgren, Zoe [D-CA-19]</fullName>
        <firstName>ZOE</firstName>
        <lastName>LOFGREN</lastName>
        <party>D</party>
        <state>CA</state>
        <district>19</district>
        <sponsorshipDate>2019-06-13</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>A000369</bioguideId>
        <fullName>Rep. Amodei, Mark E. [R-NV-2]</fullName>
        <firstName>Mark</firstName>
        <lastName>Amodei</lastName>
        <party>R</party>
        <state>NV</state>
        <middleName>E.</middleName>
        <district>2</district>
        <sponsorshipDate>2019-11-05</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2019-06-25T20:05:23Z</pubDate>
        <title>H.R. 2113, Prescription Drug STAR Act</title>
        <url>https://www.cbo.gov/publication/55392</url>
        <description>As ordered reported by the House Committee on Ways and Means on April 9, 2019</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Civil actions and liability</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Corporate finance and management</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Health care costs and insurance</name>
        </item>
        <item>
          <name>Inflation and prices</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2019-04-08</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2020-07-22T15:09:38Z</updateDate>
        <text><![CDATA[ <p><b>Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or the Prescription Drug STAR Act</b><br> <br> This bill establishes requirements for prescription drug manufacturers to provide certain information about pricing, discounts, and product samples of applicable drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to annually determine whether there are price increases of a certain threshold for outpatient prescription drugs covered under Medicare, excluding low-cost drugs.<br> <br> Manufacturers must provide HHS with an explanation for drug prices that (1) cumulatively increase by at least 10% or $10,000 over one year; (2) cumulatively increase by at least 25% or $25,000 over three years; or (3) are at least $26,000 annually, per individual, if first covered by Medicare during the applicable year. The manufacturer must explain the role of the factors contributing to such prices and other relevant information, including manufacturing costs, marketing costs, and revenue.</p> <p>Additionally, drug manufacturers must provide HHS with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.<br> <br> The bill further requires HHS to make publicly available the information related to drug discounts, rebates, and price concessions that is provided annually to HHS by group health plans. Drug manufacturers also must report to HHS certain sales information for drugs available under Medicare for which the manufacturer does not have a rebate agreement in place.<br> <br> The bill requires HHS to study and report on trends concerning inpatient hospital drug costs.</p> ]]></text>
      </summary>
      <summary>
        <versionCode>08</versionCode>
        <actionDate>2020-12-24</actionDate>
        <actionDesc>Reported to House, Part I</actionDesc>
        <updateDate>2021-01-22T20:59:54Z</updateDate>
        <text><![CDATA[ <p><b>Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or the Prescription Drug STAR Act</b><br> <br> This bill establishes requirements for prescription drug manufacturers to provide certain information about pricing, discounts, and product samples of applicable drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to annually determine whether there are price increases of a certain threshold for outpatient prescription drugs covered under Medicare, excluding low-cost drugs.<br> <br> Manufacturers must provide HHS with an explanation for drug prices that (1) cumulatively increase by at least 10% or $10,000 over one year; (2) cumulatively increase by at least 25% or $25,000 over three years; or (3) are at least $26,000 annually, per individual, if first covered by Medicare during the applicable year. The manufacturer must explain the role of the factors contributing to such prices and other relevant information, including manufacturing costs, marketing costs, and revenue.</p> <p>Additionally, drug manufacturers must provide HHS with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.<br> <br> The bill further requires HHS to make publicly available the information related to drug discounts, rebates, and price concessions that is provided annually to HHS by group health plans. Drug manufacturers also must report to HHS certain sales information for drugs available under Medicare for which the manufacturer does not have a rebate agreement in place.<br> <br> The bill requires HHS to study and report on trends concerning inpatient hospital drug costs.</p>]]></text>
      </summary>
    </summaries>
    <title>Prescription Drug STAR Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Prescription Drug STAR Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes.</title>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Prescription Drug STAR Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Prescription Drug Sunshine, Transparency, Accountability and Reporting Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>Prescription Drug STAR Act</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>Prescription Drug Sunshine, Transparency, Accountability and Reporting Act</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported in House</type>
        <date>2020-12-24T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr2113rh/xml/BILLS-116hr2113rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2019-04-08T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr2113ih/xml/BILLS-116hr2113ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-12-24</actionDate>
      <text>Placed on the Union Calendar, Calendar No. 571.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
